Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma

NCT03426891 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Brain Tumor
GBM

Interventions

DRUG: Pembrolizumab
DRUG: Vorinostat
DRUG: Temozolomide
RADIATION: Radiotherapy

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]